Ind-Swift Latest Share Price (INDSWFTLTD)
TODAY IN ONE LINE
it trades at a P/E of N/A. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.
How good is this company?
Overall performance across 5 key dimensions.
Ind-Swift flags & news
Key strengths, potential risks, and recent updates.
Green Flags
- ●Healthy Operating MarginsOPM is structurally strong at 63.5%
- ●High Promoter HoldingPromoters hold 55.6% skin-in-the-game
- ●Virtually Debt-FreeVery low Debt-to-Equity of 0.00x
- ●Zero Pledge RiskNo recent active promoter pledging found
Red Flags
No red flags identified
Latest Ind-Swift News
What changed recently?
Recent events, corporate actions, and announcements.
Ind-Swift Limited valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for Ind-Swift Limited, framed against the sector median so the premium or discount is obvious at a glance.
Market-priced ratios use the latest available quote; accounting metrics use the latest reported filing. Compare values with matched peers and the company's own history.
Valuation
Profitability
Growth
Financial Health
Ind-Swift Limited technical analysis: indicators, pivots and CPR.
Latest RSI, MACD and moving-average signals plus the latest pivot and Central Pivot Range levels for Ind-Swift Limited — derived from the latest tape, not yesterday's close.
Ind-Swift Limited last traded at ₹15.76 with an intraday range of ₹15.15–₹17.82 — latest indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Last: ₹15.76| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 22.68 | +6.92 | +43.89% |
| R3 | 20.01 | +4.25 | +26.95% |
| R2 | 18.91 | +3.15 | +20.01% |
| R1 | 17.34 | +1.58 | +10.00% |
| PIVOT | 16.24 | 0.48 | 3.07% |
| CURRENT | 15.76 | — | — |
| S1 | 14.67 | -1.09 | -6.94% |
| S2 | 13.57 | -2.19 | -13.87% |
| S3 | 12.00 | -3.76 | -23.88% |
| S4 | 9.33 | -6.43 | -40.82% |
INDSWFTLTD is trading Below CPR, indicating Bearishness
CPR is Wider, suggesting unlikely for trending moves
Day's range: ₹–₹
Trading Above opening range, showing Bullishness
Ind-Swift Limited financials: P&L, balance sheet, cash flow, ratios.
Reported annual and quarterly results for Ind-Swift Limited — consolidated or standalone — with margins, YoY growth and key ratios inline.
| Metric | Mar 2024 | Mar 2025 |
|---|---|---|
| Revenue from Operations | 502 | 515 ▲ 2.6% |
| Sales Growth YoY %Derived | 22.21% | 2.59% |
| Other Income | 58 | 48 ▼ 17.9% |
| Total Income | 560 | 563 ▲ 0.5% |
| 281 | 260 ▼ 7.5% | |
| Gross ProfitDerived | 221 | 255 ▲ 15.4% |
| Gross Margin %Derived | 44.02% | 49.50% |
| 173 | 232 ▲ 34.5% | |
| EBITDA (Operating Profit)Derived | 49 | 23 ▼ 52.6% |
| OPM %Derived | 9.66% | 4.46% |
| 90 | 343 ▲ 280.5% | |
| Profit Before Tax (PBT) | 16 | 288 ▲ 1648.8% |
| — | 4 | |
| Effective Tax %Derived | — | 1.55% |
| Total Profit for Period | 14 | 283 ▲ 1891.7% |
| Net Profit (Owner's PAT)Derived | 14 | 283 ▲ 1891.7% |
| Net Profit Margin %Derived | 2.83% | 55.01% |
| PAT Growth YoY %Derived | -45.34% | 1,891.74% |
| Earnings Per Share (EPS ₹) | 2.63 | 52.33 ▲ 1889.7% |
| Diluted Shares Outstanding (Cr) | 5 | 5 ▲ 0.0% |
| Share of Profit from Associates/JVs | — | — |
| Other Comprehensive Income (Net of Tax) | -0 | 5 ▲ 2931.0% |
| Total Expenses (incl. D&A & Interest) | 544 | 275 ▼ 49.4% |
| Material Cost % of RevenueDerived | 41.11% | 43.58% |
| Employee Cost % of RevenueDerived | 15.59% | 17.82% |
| Other Cost % of RevenueDerived | 18.76% | 27.22% |
| Interest Coverage (x)Derived | 0.34x | -0.01x |
| Period | Mar 2018 | Mar 2023 | Mar 2024 | Mar 2025 | Trend |
|---|---|---|---|---|---|
| Revenue from Operations | 271 | 411 ▲ 51.9% | 502 ▲ 22.2% | 515 ▲ 2.6% | |
| Sales Growth YoY %Derived | — | — | 22.21% | 2.59% | |
| Other Income | 10 | 12 ▲ 16.6% | 58 ▲ 389.2% | 48 ▼ 17.9% | |
| Total Income | 281 | 423 ▲ 50.6% | 560 ▲ 32.5% | 563 ▲ 0.5% | |
154 | 218 ▲ 41.4% | 281 ▲ 29.0% | 260 ▼ 7.5% | ||
| Gross ProfitDerived | 116 | 193 ▲ 65.7% | 221 ▲ 14.6% | 255 ▲ 15.4% | |
| Gross Margin %Derived | 43.03% | 46.94% | 44.02% | 49.50% | |
110 | 151 ▲ 37.0% | 173 ▲ 14.4% | 232 ▲ 34.5% | ||
| EBITDA (Operating Profit)Derived | 6 | 42 ▲ 567.7% | 49 ▲ 15.4% | 23 ▼ 52.6% | |
| OPM %Derived | 2.33% | 10.23% | 9.66% | 4.46% | |
14 | 149 ▲ 1001.1% | 90 ▼ 39.6% | 343 ▲ 280.5% | ||
| Profit Before Tax (PBT) | -53 | 26 ▲ 148.8% | 16 ▼ 36.8% | 288 ▲ 1648.8% | |
— | — | — | 4 | ||
| Effective Tax %Derived | — | — | — | 1.55% | |
| Total Profit for Period | -50 | 26 ▲ 151.6% | 14 ▼ 45.3% | 283 ▲ 1891.7% | |
| Net Profit (Owner's PAT)Derived | -50 | 26 ▲ 151.6% | 14 ▼ 45.3% | 283 ▲ 1891.7% | |
| Net Profit Margin %Derived | -18.64% | 6.34% | 2.83% | 55.01% | |
| PAT Growth YoY %Derived | — | — | -45.34% | 1,891.74% | |
| Earnings Per Share (EPS ₹) | -9.31 | 4.81 ▲ 151.7% | 2.63 ▼ 45.3% | 52.33 ▲ 1889.7% | |
| Diluted Shares Outstanding (Cr) | 5 | 5 ▲ 0.0% | 5 ▲ 0.0% | 5 ▲ 0.0% | |
| Share of Profit from Associates/JVs | 4 | — ▼ 100.0% | — | — | |
| Other Comprehensive Income (Net of Tax) | -0 | -10 ▼ 3980.6% | -0 ▲ 98.3% | 5 ▲ 2931.0% | |
| Total Expenses (incl. D&A & Interest) | 334 | 397 ▲ 18.8% | 544 ▲ 37.0% | 275 ▼ 49.4% | |
| Material Cost % of RevenueDerived | 46.33% | 47.44% | 41.11% | 43.58% | |
| Employee Cost % of RevenueDerived | 17.84% | 16.83% | 15.59% | 17.82% | |
| Other Cost % of RevenueDerived | 22.86% | 19.89% | 18.76% | 27.22% | |
| Interest Coverage (x)Derived | -4.02x | 0.22x | 0.34x | -0.01x |
Ind-Swift segment analysis : revenue and profit mix.
Disclosed business segments at Ind-Swift with their share of revenue and profit, switchable between consolidated and standalone reporting.
Ind-Swift discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
The Bull, Bear, and Flip case for Ind-Swift Limited.
Our AI distills the core fundamental drivers supporting Ind-Swift Limited, the risks that threaten it, and the quantitative conditions that could weaken the thesis.
What you're getting.
No strengths or opportunities on record.
Key Risks.
No weaknesses or threats on record.
Flip Conditions.
Reassess if quarterly profit growth turns negative for two consecutive quarters. The bull case relies on compounding earnings.
Ind-Swift Limited peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — Ind-Swift Limited is highlighted for quick read-across.
Quick Compare
Peer Comparison
| Company Name |
|---|
Ind-Swift Limited chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for Ind-Swift Limited — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
Ind-Swift Limited delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for Ind-Swift Limited over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in Ind-Swift Limited stood at 29.4% of traded volume, against a 20-day average of 57.6%.
Ind-Swift announcements: results, concalls, ratings, M&A.
Filings Ind-Swift sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
Ind-Swift files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 13 documents below.
Suspension of Trading
Members of the Exchange are hereby informed that the trading in equity shares of Ind-Swift Limited shall be suspended w.e.f. August 14, 2025 (i.e.,…
Record Date
Ind-Swift Limited has informed the Exchange that Record date for the purpose of Merger is 14-Aug-2025.
Scheme of Arrangement
Ind-Swift Limited has informed the Exchange about Scheme of Arrangement
Amalgamation/Merger
Ind-Swift Limited has informed the Exchange about Amalgamation/Merger
Resignation
Ind-Swift Limited has informed the Exchange regarding Resignation of Mr Puneet Khurana as Company Secretary & Compliance Officer of the company…
Ind-Swift dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue Ind-Swift has declared, sequenced by announce and record date.
Ind-Swift corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
About Ind-Swift Limited: business, sector, key facts.
What Ind-Swift Limited does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
Ind-Swift Limited operates in the Pharmaceuticals industry under the Healthcare sector, listed as NSE: INDSWFTLTD, BSE: 524652.
Ind-Swift Limited is a pharmaceutical company based in Chandigarh, India, established in 1983. Its core business revolves around the development, manufacturing, and distribution of a wide range of pharmaceutical products. This encompasses finished dosage forms, active pharmaceutical ingredients (APIs), and herbal formulations catering to diverse therapeutic areas.
The company's product portfolio is extensive and covers numerous therapeutic segments. These include, but are not limited to, ENT (ear, nose, and throat), dentistry, anti-infective treatments, cardio-diabetic medications, and orthopedic therapies. Specific branded products include Zoxiclav, Glypar, Olmiswif, and several others marketed under the Ind-Swift brand or related names. Beyond these specialized areas, Ind-Swift also offers a significant line of generic medications across various therapeutic categories like gynecology, pediatrics, and dermatology.
Further diversifying its offerings, Ind-Swift provides a selection of Ayurvedic products, reflecting a commitment to traditional Indian medicine. The company’s therapeutic range is incredibly broad, encompassing antibiotics, anti-cold remedies, nutraceuticals, anti-diarrheals, anti-malarials, antidepressants, cardiology medications, diabetology treatments, anti-allergics, neurological and oncology products. This demonstrates a significant presence across numerous key areas within the pharmaceutical market.
In addition to its direct sales and distribution, Ind-Swift actively engages in contract research and manufacturing services for other pharmaceutical companies. The company also leverages international markets, exporting its products and licensing its formulations to various countries, including those in Europe, Australia, Canada, South Africa, and Russia. This global reach underlines Ind-Swift's ambition and market position as a significant player in the pharmaceutical industry.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- 3B Blackbio DX (3BBLACKBIO) Share PricePeer
- Abbott India (ABBOTINDIA) Share PricePeer
- Acutaas Chemicals (ACUTAAS) Share PricePeer
- Anlon Healthcare (AHCL) Share PricePeer
- Amanta Healthcare (AMANTA) Share PricePeer
- Stocks near 52-week low (reversal watch)Screener
- Reversal Hunter strategy playbookStrategy
- Top Gainers TodayScreener
- Technical DashboardScreener
- Results CalendarScreener
- FII Buying ActivityScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy
Questions investors ask about Ind-Swift Limited (INDSWFTLTD).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of Ind-Swift Limited (INDSWFTLTD)?
The current share price of Ind-Swift Limited (INDSWFTLTD) is ₹15.76. Today, the stock has gained by ₹0.91 (6.13%), trading in a range of ₹15.15 to ₹17.82. The stock opened at ₹15.16 with a trading volume of 6,45,158 shares.
02What is the 52-week high and low price of Ind-Swift Limited stock?
The 52-week high price of Ind-Swift Limited (INDSWFTLTD) is ₹17.82, while the 52-week low is ₹15.15. Currently trading at ₹15.76, the stock is 4.03% above its 52-week low and 11.56% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
03What is the dividend yield of Ind-Swift Limited and when is the next dividend?
Ind-Swift Limited offers a dividend yield of 0%, which means for every ₹100 invested at the current price of ₹15.76, you can expect to receive approximately ₹0.00 annually as dividends. The face value of the stock is ₹2.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
04How is Ind-Swift Limited stock performing today in the market?
Ind-Swift Limited stock opened at ₹15.16 and is currently trading at ₹15.76, showing a gain of ₹0.91 (6.13%). The intraday high is ₹17.82 and low is ₹15.15. The trading volume stands at 6,45,158 shares, indicating moderate market participation today.
05What is the market capitalization of Ind-Swift Limited?
Ind-Swift Limited has a market capitalization of ₹0, making it a small-cap company. Market cap is calculated by multiplying the current stock price (₹15.76) by the total number of outstanding shares. This metric helps investors understand the company's size, stability, and investment risk profile.
06What is the ROE and ROCE of Ind-Swift Limited?
Ind-Swift Limited has a Return on Equity (ROE) of 0% and Return on Capital Employed (ROCE) of 13.4%. ROE measures how efficiently the company generates profits from shareholders' equity, while ROCE indicates how well the company uses its capital to generate profits. These returns may need improvement for better profitability. Higher percentages generally indicate better financial performance.
07Which sector and industry does Ind-Swift Limited belong to?
Ind-Swift Limited operates in the Healthcare sector and belongs to the Pharmaceuticals industry. The company competes with other players in this space and its performance is influenced by sector-specific trends, regulatory changes, and market dynamics. Understanding the sector helps investors assess growth potential, cyclical patterns, and industry-specific risks that may impact the stock's performance.
08What is the sales and profit growth of Ind-Swift Limited?
Ind-Swift Limited has reported a sales growth of 0% and profit growth of 0%. The company may be facing growth challenges or operating in a mature market. Consistent growth over multiple quarters is a positive indicator for long-term investors. Compare these growth rates with industry peers for better perspective.
The data, ratios and commentary about Ind-Swift Limited (INDSWFTLTD) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.